{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:27:23Z","timestamp":1777865243662,"version":"3.51.4"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009068","name":"Universit\u00e4t Bern","doi-asserted-by":"publisher","award":["206021_177033"],"award-info":[{"award-number":["206021_177033"]}],"id":[{"id":"10.13039\/100009068","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009068","name":"Universit\u00e4t Bern","doi-asserted-by":"publisher","award":["P13"],"award-info":[{"award-number":["P13"]}],"id":[{"id":"10.13039\/100009068","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["CRSII5-173718"],"award-info":[{"award-number":["CRSII5-173718"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_184662"],"award-info":[{"award-number":["310030_184662"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejmech.2021.113610","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T11:49:25Z","timestamp":1623152965000},"page":"113610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The quest of the best \u2013 A SAR study of trithiolato-bridged dinuclear Ruthenium(II)-Arene compounds presenting antiparasitic properties"],"prefix":"10.1016","volume":"222","author":[{"given":"Emilia","family":"P\u0103unescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0475-7548","authenticated-orcid":false,"given":"Ghalia","family":"Boubaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana","family":"Desiatkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoleta","family":"Anghel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-6211","authenticated-orcid":false,"given":"Yosra","family":"Amdouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hemphill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2096-0618","authenticated-orcid":false,"given":"Julien","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113610_bib1","first-page":"815","article-title":"Drug target identification in protozoan parasites, Expert Opin","volume":"11","author":"Muller","year":"2016","journal-title":"Drug Discov"},{"key":"10.1016\/j.ejmech.2021.113610_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpara.2020.11.001","article-title":"Control of human toxoplasmosis","volume":"51","author":"Smith","year":"2021","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113610_bib3","series-title":"Toxoplasmosis of Animals and Humans","author":"Dubey","year":"2010"},{"key":"10.1016\/j.ejmech.2021.113610_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-4017(02)00034-1","article-title":"A\u00a0review of toxoplasmosis in wild birds","volume":"106","author":"Dubey","year":"2002","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113610_bib5","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113610_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090203","article-title":"Toxoplasmosis - a global threat. Correlation of latent Toxoplasmosis with specific disease burden in a set of 88 countries","volume":"9","author":"Flegr","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2021.113610_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2471\/BLT.12.111732","article-title":"The global burden of congenital toxoplasmosis: a systematic review","volume":"91","author":"Torgerson","year":"2013","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ejmech.2021.113610_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41426-018-0164-4","article-title":"Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis","volume":"7","author":"El Bissati","year":"2018","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ejmech.2021.113610_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jogoh.2017.12.003","article-title":"An updated literature review on maternal-fetal and reproductive disorders of Toxoplasma gondii infection","volume":"47","author":"Fallahi","year":"2018","journal-title":"J.\u00a0Gynecol. Obstet. Hum. Reprod."},{"key":"10.1016\/j.ejmech.2021.113610_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1891\/0730-0832.34.5.274","article-title":"Congenital toxoplasmosis: a review","volume":"34","author":"Hampton","year":"2015","journal-title":"Neonatal Netw"},{"key":"10.1016\/j.ejmech.2021.113610_bib11","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"Montoya","year":"2004","journal-title":"Toxoplasmosis, Lancet"},{"key":"10.1016\/j.ejmech.2021.113610_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/14787210.2018.1483721","article-title":"Management of toxoplasmosis in transplant recipients: an update","volume":"16","author":"Dard","year":"2018","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2021.113610_bib13","author":"Hussain"},{"key":"10.1016\/j.ejmech.2021.113610_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of Toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2021.113610_bib15","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/AAC.02009-15","article-title":"Clinically available medicines demonstrating anti-Toxoplasma activity","volume":"59","author":"Neville","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113610_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2021.113610_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fmicb.2017.00025","article-title":"A\u00a0systematic review of in\u00a0vitro and in\u00a0vivo activities of anti-Toxoplasma drugs and compounds (2006-2016)","volume":"8","author":"Montazeri","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113610_bib18","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1128\/AAC.01176-16","article-title":"Review of experimental compounds demonstrating anti-Toxoplasma activity","volume":"60","author":"McFarland","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113610_bib19","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.3389\/fmicb.2018.02587","article-title":"Drug resistance in Toxoplasma gondii","volume":"9","author":"Montazeri","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113610_bib20","article-title":"Organometallic compounds in drug discovery: past, present and future","author":"Ong","year":"2019","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2021.113610_bib21","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1039\/D0SC04082G","article-title":"Metallodrugs are unique: opportunities and challenges of discovery and development","volume":"11","author":"Anthony","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2021.113610_bib22","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1021\/om300373t","article-title":"Challenges and opportunities in the development of organometallic anticancer drugs","volume":"31","author":"Hartinger","year":"2012","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2021.113610_bib23","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1039\/C5MD00174A","article-title":"Medicinal organometallic chemistry - an emerging strategy for the treatment of neglected tropical diseases","volume":"6","author":"Brown","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2021.113610_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1021\/acs.chemrev.8b00338","article-title":"Metal compounds against neglected tropical diseases","volume":"119","author":"Ong","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113610_bib25","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1039\/C9SC06460E","article-title":"Metal complexes as a promising source for new antibiotics","volume":"11","author":"Frei","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2021.113610_bib26","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1021\/cr400460s","article-title":"Metallodrugs in medicinal inorganic chemistry","volume":"114","author":"Mjos","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113610_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cbpa.2019.11.001","article-title":"Recent progress in the development of organometallics for the treatment of cancer","volume":"56","author":"Murray","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113610_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4155\/fmc-2017-0317","article-title":"Anticancer metallodrugs: where is the next cisplatin?","volume":"10","author":"Hanif","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jorganchem.2017.03.038","article-title":"Advances in the design of organometallic anticancer complexes","volume":"839","author":"Zhang","year":"2017","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib30","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/acs.chemrev.8b00271","article-title":"Toward multi-targeted platinum and ruthenium drugs-a new paradigm in cancer drug treatment regimens?","volume":"119","author":"Kenny","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113610_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2019.04.062","article-title":"Development and future prospects of selective organometallic compounds as anticancer drug candidates exhibiting novel modes of action","volume":"175","author":"Parveen","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jinorgbio.2017.06.002","article-title":"Recent development of transition metal complexes with in\u00a0vivo antitumor activity","volume":"177","author":"Liang","year":"2017","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2021.113610_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1389557517666170510113453","article-title":"Design of Ru-arene complexes for antitumor drugs","volume":"18","author":"Su","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib34","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1021\/acs.jmedchem.7b01689","article-title":"Ru(II) compounds: next-generation anticancer metallotherapeutics?","volume":"61","author":"Thota","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1021\/om100964h","article-title":"Bioorganometallics: future trends in drug discovery, analytical chemistry, and catalysis","volume":"30","author":"Hillard","year":"2011","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2021.113610_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccr.2015.10.007","article-title":"Thiolato-bridged dinuclear arene ruthenium complexes and their potential as anticancer drugs","volume":"309","author":"Furrer","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113610_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ica.2017.07.068","article-title":"Design of prospective antiparasitic metal-based compounds including selected organometallic cores","volume":"472","author":"Gambino","year":"2018","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.ejmech.2021.113610_bib38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/cmdc.200700127","article-title":"Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial","volume":"3","author":"Dive","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113610_bib39","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1021\/om300296n","article-title":"Bioorganometallic compounds with antimalarial targets: inhibiting hemozoin formation","volume":"31","author":"Navarro","year":"2012","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2021.113610_bib40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1051\/parasite\/2011183207","article-title":"The antimalarial ferroquine: from bench to clinic","volume":"18","author":"Biot","year":"2011","journal-title":"Parasite"},{"key":"10.1016\/j.ejmech.2021.113610_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01947-16","article-title":"Phase I clinical trial results of auranofin, a novel antiparasitic agent","volume":"61","author":"Capparelli","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113610_bib42","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1128\/AAC.00057-15","article-title":"Reduction of Toxoplasma gondii development due to inhibition of parasite antioxidant enzymes by a dinuclear iron(III) compound","volume":"59","author":"Portes","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113610_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.inoche.2016.02.017","article-title":"Synthesis, crystal structure and relevant antiproliferative activity against Toxoplasma gondii of a new binuclear Co(II) complex","volume":"67","author":"de Assis","year":"2016","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113610_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vetpar.2017.04.002","article-title":"In\u00a0vitro treatment of Toxoplasma gondii with copper(II) complexes induces apoptosis-like and cellular division alterations","volume":"245","author":"Portes","year":"2017","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113610_bib45","doi-asserted-by":"crossref","first-page":"100606","DOI":"10.1039\/C5RA17690E","article-title":"Antiproliferative activity and conversion of tachyzoite to bradyzoite of Toxoplasma gondii promoted by new zinc complexes containing sulfadiazine","volume":"5","author":"Batista","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2021.113610_bib46","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1007\/s00436-018-5967-7","article-title":"A\u00a0new iron(III) complex-containing sulfadiazine inhibits the proliferation and induces cystogenesis of Toxoplasma gondii","volume":"117","author":"Portes","year":"2018","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2021.113610_bib47","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/14756366.2017.1316494","article-title":"Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives","volume":"32","author":"Carradori","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib48","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.bmc.2005.09.054","article-title":"Synthesis and in\u00a0vitro activities of ferrocenic aminohydroxynaphthoquinones against Toxoplasma gondii and Plasmodium falciparum","volume":"14","author":"Baramee","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib49","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1128\/AAC.02446-12","article-title":"In\u00a0vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites","volume":"57","author":"Barna","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113610_bib50","first-page":"61","article-title":"Characterization of the activities of dinuclear thiolato-bridged arene ruthenium complexes against Toxoplasma gondii","author":"Basto","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113610_bib51","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1002\/cbic.202000174","article-title":"Coumarin-tagged dinuclear trithiolato-bridged ruthenium(II)arene complexes: photophysical properties and antiparasitic activity","volume":"21","author":"Desiatkina","year":"2020","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2021.113610_bib52","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/ph13120471","article-title":"Conjugates containing two and three trithiolato-bridged dinuclear ruthenium(II)-arene units as in\u00a0Vitro antiparasitic and anticancer agents","volume":"13","author":"Studer","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2021.113610_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002973","article-title":"Auranofin is highly efficacious against Toxoplasma gondii in\u00a0vitro and in an in\u00a0vivo experimental model of acute toxoplasmosis","volume":"8","author":"Andrade","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2021.113610_bib54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fcimb.2018.00360","article-title":"A\u00a0perspective on thiazolidinone scaffold development as a new therapeutic strategy for Toxoplasmosis","volume":"8","author":"Rocha-Roa","year":"2018","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113610_bib55","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/AAC.37.11.2371","article-title":"In\u00a0vitro and in\u00a0vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii","volume":"37","author":"Romand","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113610_bib56","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1021\/jm300291a","article-title":"A\u00a0new promising application for highly cytotoxic metal compounds: eta(6)-arene ruthenium(II) phosphite complexes for the treatment of alveolar Echinococcosis","volume":"55","author":"Kuster","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib57","first-page":"462","article-title":"Targeting of the mitochondrion by dinuclear thiolato-bridged arene ruthenium complexes in cancer cells and in the apicomplexan parasite Neospora caninum","volume":"11","author":"Basto","year":"2019","journal-title":"Metall"},{"key":"10.1016\/j.ejmech.2021.113610_bib58","doi-asserted-by":"crossref","first-page":"107753","DOI":"10.1016\/j.exppara.2019.107753","article-title":"Anti-parasitic dinuclear thiolato-bridged arene ruthenium complexes alter the mitochondrial ultrastructure and membrane potential in Trypanosoma brucei bloodstream forms","volume":"205","author":"Jelk","year":"2019","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113610_bib59","first-page":"25","article-title":"Recent advances in the biological investigation of organometallic platinum-group metal (Ir, Ru, Rh, Os, Pd, Pt) complexes as antimalarial agents","author":"Mbaba","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113610_bib60","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.trechm.2019.05.001","article-title":"Extrapolating the fragment-based approach to inorganic drug discovery","volume":"1","author":"Batchelor","year":"2019","journal-title":"Trends Chem"},{"key":"10.1016\/j.ejmech.2021.113610_bib61","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1039\/C9SC05586J","article-title":"Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery","volume":"11","author":"Morrison","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2021.113610_bib62","series-title":"Advances in Inorganic Chemistry, Volume: Medicinal Chemistry","first-page":"257","author":"Zhao","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113610_bib63","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1021\/jm500455p","article-title":"Discovery and investigation of anticancer ruthenium-arene Schiff-base complexes via water-promoted combinatorial three-component assembly","volume":"57","author":"Chow","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib64","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1039\/c0dt00034e","article-title":"Discovery of a strongly apoptotic ruthenium complex through combinatorial coordination chemistry","volume":"39","author":"Mulcahy","year":"2010","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2021.113610_bib65","first-page":"813","article-title":"Comparative high-throughput analysis of the Trypanosoma cruzi response to organometallic compounds","volume":"12","author":"Mosquillo","year":"2020","journal-title":"Metall"},{"key":"10.1016\/j.ejmech.2021.113610_bib66","first-page":"1634270","article-title":"High throughput approaches to unravel the mechanism of action of a new vanadium-based compound against Trypanosoma cruzi","author":"Mosquillo","year":"2020","journal-title":"Bioinorg. Chem. Appl., 2020"},{"key":"10.1016\/j.ejmech.2021.113610_bib67","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1039\/C7CS00332C","article-title":"Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development","volume":"47","author":"Meier-Menches","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2021.113610_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2018.10.019","article-title":"Structure-activity relationship studies of antiplasmodial cyclometallated ruthenium(II), rhodium(III) and iridium(III) complexes of 2-phenylbenzimidazoles","volume":"161","author":"Rylands","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib69","doi-asserted-by":"crossref","first-page":"112084","DOI":"10.1016\/j.ejmech.2020.112084","article-title":"Identification of descriptors for structure-activity relationship in ruthenium (II) mixed compounds with antiparasitic activity","volume":"189","author":"Cedillo-Gutierrez","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib70","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1021\/jm060596m","article-title":"Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands","volume":"49","author":"Habtemariam","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib71","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ejmech.2018.04.044","article-title":"Structure-activity relationships of anticancer ruthenium(II) complexes with substituted hydroxyquinolines","volume":"156","author":"Havrylyuk","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib72","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1021\/jm3000906","article-title":"A\u00a0SAR study of novel antiproliferative ruthenium and osmium complexes with quinoxalinone ligands in human cancer cell lines","volume":"55","author":"Ginzinger","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib73","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/ejic.201101057","article-title":"Thiolato-bridged arene-ruthenium complexes: synthesis, molecular structure, reactivity, and anticancer activity of the dinuclear complexes [(arene)2Ru2(SR)2Cl2]","author":"Ibao","year":"2012","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib74","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1039\/c3nj00476g","article-title":"Highly cytotoxic diruthenium trithiolato complexes of the type [(eta(6)-p-MeC6H4Pri)(2)Ru-2(mu(2)-SR)(3)](+): synthesis, characterization, molecular structure and in\u00a0vitro anticancer activity","volume":"37","author":"Giannini","year":"2013","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib75","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00775-012-0911-2","article-title":"Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(eta6-p-MeC6H4Pri)2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential","volume":"17","author":"Giannini","year":"2012","journal-title":"J.\u00a0Biol. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jorganchem.2013.04.049","article-title":"Synthesis, characterization and in\u00a0vitro anticancer activity of highly cytotoxic trithiolato diruthenium complexes of the type [(eta(6)-p-(MeC6H4Pr)-Pr-i)(2)Ru-2(mu(2)-SR1)(2)(mu(2)-SR2)](+) containing different thiolato bridges","volume":"744","author":"Giannini","year":"2013","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib77","first-page":"1174","article-title":"Crystal structure of (mu-4-hy-droxy-benzene-thiol-ato-kappa(2) S:S)bis-(mu-phenyl-methane-thiol-ato-kappa(2) S:S)bis-[(eta(6)-1-isopropyl-4-methyl-benzene)-ruthenium(II)] tetra-fluorido-borate","volume":"71","author":"Stibal","year":"2015","journal-title":"Acta Crystallogr. E: Crystallogr. Commun."},{"key":"10.1016\/j.ejmech.2021.113610_bib78","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0277-5387(02)01376-1","article-title":"Specific reactivity of SH versus OH functions towards dinuclear arene ruthenium units: synthesis of cationic complexes of the type [(arene)(2)Ru(2)(SR)(3)](+)","volume":"22","author":"Cherioux","year":"2003","journal-title":"Polyhedron"},{"key":"10.1016\/j.ejmech.2021.113610_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ph13120471","article-title":"Conjugates containing two and three trithiolato-bridged dinuclear ruthenium(II)-arene anits as in\u00a0vitro antiparasitic and anticancer agents","volume":"13","author":"Studer","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2021.113610_bib80","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00011-003-1169-5","article-title":"In\u00a0vitro immunomodulatory activity of ruthenium complexes","volume":"52","author":"Newcomb","year":"2003","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejmech.2021.113610_bib81","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0960-894X(97)10205-0","article-title":"Synthesis and immunosuppressive activity of ruthenium complexes","volume":"8","author":"Bastos","year":"1998","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113610_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004857","article-title":"Integrating antimicrobial therapy with host immunity to fight drug-resistant infections: classical vs. adaptive treatment","volume":"12","author":"Gjini","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejmech.2021.113610_bib83","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1084\/jem.139.1.74","article-title":"Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses","volume":"139","author":"Coutinho","year":"1974","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ejmech.2021.113610_bib84","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4049\/jimmunol.128.3.1026","article-title":"Preferential induction of autoantibody secretion in polyclonal activation by peptidoglycan and lipopolysaccharide. II. In\u00a0vivo studies","volume":"128","author":"Dziarski","year":"1982","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2021.113610_bib85","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4049\/jimmunol.128.1.337","article-title":"Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation","volume":"128","author":"Palacios","year":"1982","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2021.113610_bib86","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/ncomms3406","article-title":"Quantal and graded stimulation of B lymphocytes as alternative strategies for regulating adaptive immune responses","volume":"4","author":"Hawkins","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113610_bib87","series-title":"Diffraction ltd","author":"Oxford","year":"2018"},{"key":"10.1016\/j.ejmech.2021.113610_bib88","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1107\/S0021889811016232","article-title":"Low-energy contamination of Mo microsource X-ray radiation: analysis and solution of the problem","volume":"44","author":"Macchi","year":"2011","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2021.113610_bib89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"Shelxt - integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. A: Found. Adv."},{"key":"10.1016\/j.ejmech.2021.113610_bib90","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C: Struct. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib91","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: a complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2021.113610_bib92","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1107\/S2053229614024929","article-title":"Platon SQUEEZE: a tool for the calculation of the disordered solvent contribution to the calculated structure factors","volume":"71","author":"Spek","year":"2015","journal-title":"Acta Crystallogr. C: Struct. Chem."},{"key":"10.1016\/j.ejmech.2021.113610_bib93","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1128\/AAC.01236-15","article-title":"In\u00a0vitro and in\u00a0vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans Toxoplasma gondii and Neospora caninum","volume":"59","author":"Winzer","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113610_bib94","doi-asserted-by":"crossref","DOI":"10.1186\/s13567-016-0317-1","article-title":"Repurposing of antiparasitic drugs: the hydroxy-naphthoquinone buparvaquone inhibits vertical transmission in the pregnant neosporosis mouse model","volume":"47","author":"Muller","year":"2016","journal-title":"Vet. Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421004591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421004591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:00:59Z","timestamp":1777528859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421004591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":94,"alternative-id":["S0223523421004591"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113610","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The quest of the best \u2013 A SAR study of trithiolato-bridged dinuclear Ruthenium(II)-Arene compounds presenting antiparasitic properties","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113610"}}